AUTOIMMUNE CHOLESTATIC LESIONS OF BILIARY DUCTS
Abstract
The review presents literature data and original findings of light and electron microscopy of pathomorphological changes in the bile ducts in primary sclerosing cholangitis (PSC), immunoglobulin G4 (IgG4)-associated autoimmune sclerosing cholangitis and overlap syndromes: PSC + chronic autoimmune hepatitis (AIH); PSC + primary biliary cirrhosis (PBC).
References
Lleo A, Maroni L, Glaser S, Alpini G, Marzioni M. Role of cholangiocytes in primary biliary cirrhosis. Semin Liver Dis. 2014;34(3):273-284. https://doi.org/10.1055/s-0034-1383727.
Gochanour E, Jayasekera C, Kowdley K. Primary Sclerosing Cholangitis: Epidemiology, Genetics, Diagnosis, and Current Management. Clin Liver Dis. 2020;15(3):125-128. https://doi.org/10.1002/cld.902.
Hirschfield GM, Karlsen TH, Lindor KD, Adams DH. Primary sclerosing cholangitis. Lancet. 2013;382(9904):1587-1599. https://doi.org/10.1016/S0140-6736(13)60096-3.
Ludwig J. New concepts in biliary cirrhosis. Semin Liver Dis. 1987;7(4):293-301. https://doi.org/10.1055/s-2008-1040584.
Kanno N, LeSage G, Glaser S, Alvaro D. Alpini G. Functional heterogeneity of the intrahepatic biliary epithelium. Hepatology. 2000;31(3):555-561. https://doi.org/10.1002/hep.510310302.
Chapman R, Fevery J, Kalloo A, Nagorney DM, Boberg KM, Shneider B, Gores GJ. Diagnosis and management of primary sclerosing cholangitis. Hepatology. 2010;51(2):660-678. https://doi.org/10.1002/hep.23294.
Lindor KD, Kowdley KV, Harrison ME. ACG Clinical Guideline: Primary Sclerosing Cholangitis. Am J Gastroenterol. 2015;110(5):646-659;quiz 660. https://doi.org/10.1038/ajg.2015.112.
Chascsa DM, Lindor KD. Antimitochondrial AntibodyNegative Primary Biliary Cholangitis: Is It Really the Same Disease? Clin Liver Dis. 2018;22(3):589-601. https://doi.org/10.1016/j.cld.2018.03.009.
Karlsen TH, Folseraas T, Thorburn D, Vesterhus M. Primary sclerosing cholangitis – a comprehensive review. J Hepatol. 2017;67(6):1298-1323. https://doi.org/10.1016/j.jhep.2017.07.022.
Molodecky NA, Myers RP, Barkema HW, Quan H, Kaplan GG. Validity of administrative data for the diagnosis of primary sclerosing cholangitis: a population-based study. Liver Int. 2011;31(5):712-720. https://doi.org/10.1111/j.1478-3231.2011.02484.x.
Trivedi PJ, Adams DH. Mucosal immunity in liver autoimmunity: a comprehensive review. J Autoimmun. 2013;46:97-111. https://doi.org/10.1016/j.jaut.2013.06.013.
Hov, JR, Boberg KM, Karlsen TH. Autoantibodies in primary sclerosing cholangitis. World J Gastroenterol. 2008;14(24):3781-3791. https://doi.org/10.3748/wjg.14.3781.
Trauner M, Meier PJ, Boyer JL. Molecular pathogenesis of cholestasis. N Engl J Med. 1998;339(17):1217-1227. https://doi.org/10.1056/NEJM199810223391707.
Dutta AK, Khimji A-K, Kresge C, Sathe M, Kresge C, Parameswara V, Esser V, Rockey DC, Feranchak AP. Identification and functional characterization of TMEM16A, a Ca2+-activated Cl- channel activated by extracellular nucleotides, in biliary epithelium. J Biol Chem. 2011;286(1):766-776. https://doi.org/10.1074/jbc.M110.164970.
Keitel V, Ullmer C, Häussinger D. The membrane-bound bile acid receptor TGR5 (Gpbar-1) is localized in the primary cilium of cholangiocytes. Biol Chem. 2010;391(7):785-789. https://doi.org/10.1515/BC.2010.077.
Keitel V, Cupisti K, Ullmer C, Knoefel WT, Kubitz R, Häussinger D. The membrane-bound bile acid receptor TGR5 is localized in the epithelium of human gallbladders. Hepatology. 2009;50(3):861-870. https://doi.org/10.1002/hep.23032.
O’Hara SP, Karlsen TH, LaRusso NF. Cholangiocytes and the environment in primary sclerosing cholangitis: where is the link? Gut. 2017;66(11):1873-1877. https://doi.org/10.1136/gutjnl-2017-314249.
Kamihira T, Shimoda S, Nakamura M, Yokoyama T, Takii Y, Kawano A, Handa M, Ishibashi H, Gershwin ME, Harada M. Biliary epithelial cells regulate autoreactive T cells: implications for biliary-specific diseases. Hepatology. 2005;41(1):151-159. https://doi.org/10.1002/hep.20494.
Cameron RG, Blendis LM, Neuman MG. Accumulation of macrophages in primary sclerosing cholangitis. Clin Biochem. 2001;34(3):195-201. https://doi.org/10.1016/s0009-9120(01)00215-6.
Mederacke I, Hsu CC, Troeger JS, Huebener P, Mu X, Dapito DH, Pradere J-P, Schwabe RF. Fate tracing reveals hepatic stellate cells as dominant contributors to liver fibrosis independent of its etiology. Nat Commun. 2013;4:2823. https://doi.org/10.1038/ncomms3823.
Yan HP, Zhang HP, Chen XX. How to understand the clinical significance of autoantibodies in primary biliary cholangitis. Zhonghua Gan Zang Bing Za Zhi. 2017;25(11):810-815. https://doi.org/10.3760/cma.j.issn.1007-3418.2017.11.003.
Kim WR, Ludwig J, Lindor KD. Variant forms of cholestatic diseases involving small bile ducts in adults. Am J Gastroenterol. 2000;95(5):1130-1138. https://doi.org/10.1111/j.1572-0241.2000.01999.x.
van Buuren HR, van Hoogstraten HJE, Terkivatan T, Schalm SW, Vleggaar FP. High prevalence of autoimmune hepatitis among patients with primary sclerosing cholangitis. J Hepatol. 2000;33(4):543-548. https://doi.org/10.1034/j.1600-0641.2000.033004543.x.
Herta T, Beuers U. Autoimmunassoziierte Gallenwegserkrankungen : Diagnostische und therapeutische Herausforderungen [Immune-mediated cholangiopathies : Diagnostic and therapeutic challenges]. Der Radiologe. 2019;59(4):348-356. https://doi.org/10.1007/s00117-019-0513-x. (German).
Lee HE, Zhang L. Immunoglobulin G4-related hepatobiliary disease. Semin Diagn Pathol. 2019;36(6):423-433. https://doi.org/10.1053/j.semdp.2019.07.007.
Nakazawa T, Ohara H, Sano H, Ando T, Joh T. Schematic classification of sclerosing cholangitis with autoimmune pancreatitis by cholangiography. Pancreas. 2006;32(2):229. https://doi.org/10.1097/01.mpa.0000202941.85955.07.
Goodchild G. Pereira SP, Webster G. Immunoglobulin G4-related sclerosing cholangitis. Korean J Intern Med. 2018;33(5):841-850. https://doi.org/10.3904/kjim.2018.018.
Strassburg CP. Autoimmune liver diseases and their overlap syndromes. Praxis. 2006;95(36):1363-1381. https://doi.org/10.1024/1661-8157.95.36.1363.
Bairy I, Berwal A, Seshadri S. Autoimmune Hepatitis – Primary Biliary Cirrhosis Overlap Syndrome. J Clin Diagn Res. 2017;11(7):OD07-OD09. https://doi.org/10.7860/JCDR/2017/25193.10242.
Chazouilleres O, Wendum D, Serfaty L, Montembault S, Rosmorduc O, Poupon R. Primary biliary cirrhosis–autoimmune hepatitis overlap syndrome: Clinical features and response to therapy. Hepatology. 1998;28(2):296-301. https://doi.org/10.1002/hep.510280203.
Rust C, Beuers U. Overlap syndromes among autoimmune liver diseases. World J Gastroenterol. 2008;14(21):3368-3373. https://doi.org/10.3748/wjg.14.3368.
Aizawa Y, Hokari A. Autoimmune hepatitis: current challenges and future prospects. Clin Exp Gastroenterol. 2017;10:9-18. https://doi.org/10.2147/CEG.S101440.
Kobayashi M, Kakuda Y, Harada K, Sato Y, Sasaki M, Ikeda H, Terada M, Mukai M, Kaneko S, Nakanuma Y. Clinicopathological study of primary biliary cirrhosis with interface hepatitis compared to autoimmune hepatitis. World J Gastroenterol. 2014;20(13):3597-3608. https://doi.org/10.3748/wjg.v20.i13.3597.
Kuiper EM, Zondervan PE, van Buuren HR. Paris criteria are effective in diagnosis of primary biliary cirrhosis and autoimmune hepatitis overlap syndrome. Clin Gastroenterol Hepatol. 2010;8(6):530-534. https://doi.org/10.1016/j.cgh.2010.03.004.
Verdonk RC, Lozano MF, van den Berg AP, Gouw ASH. Bile ductal injury and ductular reaction are frequent phenomena with different significance in autoimmune hepatitis. Liver Int. 2016;36(9):1362-1369. https://doi.org/10.1111/liv.13083.
Yamamoto K, Terada R, Okamoto R, Hiasa Y, Abe M, Onji M, Tsuji T. A scoring system for primary biliary cirrhosis and its application for variant forms of autoimmune liver disease. J Gastroenterol. 2003;38(1):52-59. https://doi.org/10.1007/s005350300006.
Bioulac-Sage P. Primary biliary cirrhosis: a new histological staging and grading system proposed by Japanese authors. Clin Res Hepatol. Gastroenterol. 2011;35(5):333-335. https://doi.org/10.1016/j.clinre.2011.03.001.
1.png)
